Advertisement
Screener

Apnimed, Inc. (APMD) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Apnimed, Inc. (APMD) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
40 QUARTERS × 3 ROAST BATTLES
0/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseAPMD / S&P
APMD unavailable / 15.20% 		LoseAPMD / S&P
APMD unavailable / 15.00% 		LoseAPMD / S&P
APMD unavailable / 50.40%
2026-Q10/3 LoseAPMD / S&P
APMD unavailable / -4.33% 		LoseAPMD / S&P
APMD unavailable / 11.30% 		LoseAPMD / S&P
APMD unavailable / 27.70%
2025-Q40/3 LoseAPMD / S&P
APMD unavailable / 2.65% 		LoseAPMD / S&P
APMD unavailable / 9.00% 		LoseAPMD / S&P
APMD unavailable / 13.40%
2025-Q30/3 LoseAPMD / S&P
APMD unavailable / 8.12% 		LoseAPMD / S&P
APMD unavailable / 4.61% 		LoseAPMD / S&P
APMD unavailable / 13.45%
2025-Q20/3 LoseAPMD / S&P
APMD unavailable / 10.94% 		LoseAPMD / S&P
APMD unavailable / 4.83% 		LoseAPMD / S&P
APMD unavailable / 10.63%
2025-Q10/3 LoseAPMD / S&P
APMD unavailable / -4.27% 		LoseAPMD / S&P
APMD unavailable / 4.98% 		LoseAPMD / S&P
APMD unavailable / 10.57%
2024-Q40/3 LoseAPMD / S&P
APMD unavailable / 2.41% 		LoseAPMD / S&P
APMD unavailable / 5.25% 		LoseAPMD / S&P
APMD unavailable / 6.15%
2024-Q30/3 LoseAPMD / S&P
APMD unavailable / 5.89% 		LoseAPMD / S&P
APMD unavailable / 5.89% 		LoseAPMD / S&P
APMD unavailable / 6.11%
2024-Q20/3 LoseAPMD / S&P
APMD unavailable / 4.28% 		LoseAPMD / S&P
APMD unavailable / 5.38% 		LoseAPMD / S&P
APMD unavailable / 5.12%
2024-Q10/3 LoseAPMD / S&P
APMD unavailable / 10.56% 		LoseAPMD / S&P
APMD unavailable / 5.71% 		LoseAPMD / S&P
APMD unavailable / 5.59%
2023-Q40/3 LoseAPMD / S&P
APMD unavailable / 11.69% 		LoseAPMD / S&P
APMD unavailable / 6.81% 		LoseAPMD / S&P
APMD unavailable / 7.78%
2023-Q30/3 LoseAPMD / S&P
APMD unavailable / -3.27% 		LoseAPMD / S&P
APMD unavailable / 7.52% 		LoseAPMD / S&P
APMD unavailable / -5.03%
2023-Q20/3 LoseAPMD / S&P
APMD unavailable / 8.74% 		LoseAPMD / S&P
APMD unavailable / 9.50% 		LoseAPMD / S&P
APMD unavailable / -8.57%
2023-Q10/3 LoseAPMD / S&P
APMD unavailable / 7.50% 		LoseAPMD / S&P
APMD unavailable / 10.77% 		LoseAPMD / S&P
APMD unavailable / -15.69%
2022-Q40/3 LoseAPMD / S&P
APMD unavailable / 7.56% 		LoseAPMD / S&P
APMD unavailable / 11.88% 		LoseAPMD / S&P
APMD unavailable / -17.99%
2022-Q30/3 LoseAPMD / S&P
APMD unavailable / -4.88% 		LoseAPMD / S&P
APMD unavailable / 13.47% 		LoseAPMD / S&P
APMD unavailable / -1.41%
2022-Q20/3 LoseAPMD / S&P
APMD unavailable / -16.10% 		LoseAPMD / S&P
APMD unavailable / 13.71% 		LoseAPMD / S&P
APMD unavailable / 11.04%
2022-Q10/3 LoseAPMD / S&P
APMD unavailable / -4.60% 		LoseAPMD / S&P
APMD unavailable / 15.97% 		LoseAPMD / S&P
APMD unavailable / 42.23%
2021-Q40/3 LoseAPMD / S&P
APMD unavailable / 11.03% 		LoseAPMD / S&P
APMD unavailable / 15.00% 		LoseAPMD / S&P
APMD unavailable / 96.40%
2021-Q30/3 LoseAPMD / S&P
APMD unavailable / 0.58% 		LoseAPMD / S&P
APMD unavailable / 10.77% 		LoseAPMD / S&P
APMD unavailable / 69.42%
2021-Q20/3 LoseAPMD / S&P
APMD unavailable / 8.55% 		LoseAPMD / S&P
APMD unavailable / 6.58% 		LoseAPMD / S&P
APMD unavailable / 51.81%
2021-Q10/3 LoseAPMD / S&P
APMD unavailable / 6.17% 		LoseAPMD / S&P
APMD unavailable / -1.06% 		LoseAPMD / S&P
APMD unavailable / 7.39%
2020-Q40/3 LoseAPMD / S&P
APMD unavailable / 12.15% 		LoseAPMD / S&P
APMD unavailable / -3.72% 		LoseAPMD / S&P
APMD unavailable / -33.42%
2020-Q30/3 LoseAPMD / S&P
APMD unavailable / 8.93% 		LoseAPMD / S&P
APMD unavailable / -2.04% 		LoseAPMD / S&P
APMD unavailable / -27.10%
2020-Q20/3 LoseAPMD / S&P
APMD unavailable / 20.54% 		LoseAPMD / S&P
APMD unavailable / -0.46% 		LoseAPMD / S&P
APMD unavailable / -27.11%
2020-Q10/3 LoseAPMD / S&P
APMD unavailable / -19.60% 		LoseAPMD / S&P
APMD unavailable / 3.47% 		LoseAPMD / S&P
APMD unavailable / -14.75%
2019-Q40/3 LoseAPMD / S&P
APMD unavailable / 9.07% 		LoseAPMD / S&P
APMD unavailable / 5.36% 		LoseAPMD / S&P
APMD unavailable / 2.99%
2019-Q30/3 LoseAPMD / S&P
APMD unavailable / 1.70% 		LoseAPMD / S&P
APMD unavailable / 5.02% 		LoseAPMD / S&P
APMD unavailable / 0.21%
2019-Q20/3 LoseAPMD / S&P
APMD unavailable / 4.30% 		LoseAPMD / S&P
APMD unavailable / 6.64% 		LoseAPMD / S&P
APMD unavailable / 8.65%
2019-Q10/3 LoseAPMD / S&P
APMD unavailable / 13.65% 		LoseAPMD / S&P
APMD unavailable / 8.12% 		LoseAPMD / S&P
APMD unavailable / 14.29%
2018-Q40/3 LoseAPMD / S&P
APMD unavailable / -13.52% 		LoseAPMD / S&P
APMD unavailable / 9.05% 		LoseAPMD / S&P
APMD unavailable / 18.23%
2018-Q30/3 LoseAPMD / S&P
APMD unavailable / 7.71% 		LoseAPMD / S&P
APMD unavailable / 10.21% 		LoseAPMD / S&P
APMD unavailable / 19.06%
2018-Q20/3 LoseAPMD / S&P
APMD unavailable / 3.43% 		LoseAPMD / S&P
APMD unavailable / 9.03% 		LoseAPMD / S&P
APMD unavailable / 14.46%
2018-Q10/3 LoseAPMD / S&P
APMD unavailable / -0.76% 		LoseAPMD / S&P
APMD unavailable / 7.68% 		LoseAPMD / S&P
APMD unavailable / 12.46%
2017-Q40/3 LoseAPMD / S&P
APMD unavailable / 6.64% 		LoseAPMD / S&P
APMD unavailable / 7.03% 		LoseAPMD / S&P
APMD unavailable / 13.82%
2017-Q30/3 LoseAPMD / S&P
APMD unavailable / 4.48% 		LoseAPMD / S&P
APMD unavailable / 5.68% 		LoseAPMD / S&P
APMD unavailable / 17.57%
2017-Q20/3 LoseAPMD / S&P
APMD unavailable / 3.09% 		LoseAPMD / S&P
APMD unavailable / 4.83% 		LoseAPMD / S&P
APMD unavailable / 17.74%
2017-Q10/3 LoseAPMD / S&P
APMD unavailable / 6.07% 		LoseAPMD / S&P
APMD unavailable / 3.67% 		LoseAPMD / S&P
APMD unavailable / 13.32%
2016-Q40/3 LoseAPMD / S&P
APMD unavailable / 3.82% 		LoseAPMD / S&P
APMD unavailable / 2.09% 		LoseAPMD / S&P
APMD unavailable / 7.05%
2016-Q30/3 LoseAPMD / S&P
APMD unavailable / 3.85% 		LoseAPMD / S&P
APMD unavailable / 0.20% 		LoseAPMD / S&P
APMD unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2026-07-31 to 2026-08-27

MetricAPMD total returnS&P 500 Total Return Index
Total return14.88%20.78%
Annualized return14.88%20.78%

5Y · 2026-07-31 to 2026-08-27

MetricAPMD total returnS&P 500 Total Return Index
Total return14.88%83.14%
Annualized return2.81%12.86%

10Y · 2026-07-31 to 2026-08-27

MetricAPMD total returnS&P 500 Total Return Index
Total return14.88%319.30%
Annualized return1.40%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Advertisement